Literature DB >> 26062560

A prolonged outbreak of invasive meningococcal disease in an extended Irish Traveller family across three Health Service Executive (HSE) areas in Ireland, 2010 to 2013.

L O'Connor1, M Ward, D Bennett, R Mulhall, P O'Lorcain, R Cunney, R McDermott, E Neville, J Heslin, R FitzGerald, K Meyler, M Conlon, A Clarke, B Corcoran, G Fitzpatrick, B O'Connor, P Flanagan, D O'Flanagan, S Cotter.   

Abstract

Between March 2010 and November 2013 eight laboratory-confirmed cases of serogroup B, invasive meningococcal disease (IMD) were identified in an extended Irish Traveller family across three Health Service Executive (HSE) areas of Ireland. Cases were aged between 5 and 46 months, and were either a cousin or sibling of another case. All eight cases survived. Chemoprophylaxis was given to relevant nuclear family members and close contacts on each occasion, but failed to prevent further cases. Neisseria meningitidis isolates from six cases were highly related, belonging to the ST-41/44 clonal complex, and shared the porA designation 7–2,4. In November 2013, the outbreak control team recommended that directly observed ciprofloxacin chemoprophylaxis be administered simultaneously to the extended family, and that the four component meningococcal B (4CMenB) vaccine be administered to family members aged 2 months to 23 years inclusive and relevant close contacts of the eighth case. Subsequently these recommendations were implemented at three regional clinics. Additionally pharyngeal swabs (n=112) were collected to assess carriage rates of N. meningitidis in this extended family. Pharyngeal carriage of N. meningitidis was detected in 15 (13%) family members. From the epidemiological investigation and carriage study overcrowding was the most likely risk factor identified in this outbreak. To date, the combination of directly observed ciprofloxacin chemoprophylaxis and use of 4CMenB vaccine have controlled the outbreak with no further cases diagnosed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26062560     DOI: 10.2807/1560-7917.es2015.20.21.21139

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  5 in total

1.  Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period, 1996-2015.

Authors:  Désirée E Bennett; Kenneth L Meyler; Mary T Cafferkey; Robert J Cunney
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

2.  Risk factors for carriage of meningococcus in third-level students in Ireland: an unsupervised machine learning approach.

Authors:  Richard J Drew; Desirée Bennett; Sinéad O'Donnell; Robert Mulhall; Robert Cunney
Journal:  Hum Vaccin Immunother       Date:  2021-06-24       Impact factor: 4.526

3.  Resolution of a Protracted Serogroup B Meningococcal Outbreak with Whole-Genome Sequencing Shows Interspecies Genetic Transfer.

Authors:  Robert M Mulhall; Carina Brehony; Lois O'Connor; Kenneth Meyler; Keith A Jolley; James Bray; Desiree Bennett; Martin C J Maiden; Robert Cunney
Journal:  J Clin Microbiol       Date:  2016-09-14       Impact factor: 5.948

Review 4.  Meningococcal serogroup B vaccines: Estimating breadth of coverage.

Authors:  Robert G K Donald; Julio Cesar Hawkins; Li Hao; Paul Liberator; Thomas R Jones; Shannon L Harris; John L Perez; Joseph J Eiden; Kathrin U Jansen; Annaliesa S Anderson
Journal:  Hum Vaccin Immunother       Date:  2016-12-14       Impact factor: 3.452

5.  Ethnicity recording in health and social care data collections in Ireland: where and how is it measured and what is it used for?

Authors:  Ailish Hannigan; Nazmy Villarroel; Maria Roura; Joseph LeMaster; Alphonse Basogomba; Colette Bradley; Anne MacFarlane
Journal:  Int J Equity Health       Date:  2019-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.